Advances in pancreatic cancer detection (Q37790673)

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

New aspects of regulatory signaling pathways and novel therapies in pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Progress on molecular markers of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Caveolin-1: a marker for pancreatic cancer diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Identifying molecular markers for the early detection of pancreatic neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Pancreatic cancer: a plea for good and comprehensive morphological studies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

A mouse to human search for plasma proteome changes associated with pancreatic tumor development

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Evaluation of clinical relevance of examining K-ras, p16 and p53 mutations along with allelic losses at 9p and 18q in EUS-guided fine needle aspiration samples of patients with chronic pancreatitis and pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Molecular biomarkers: their increasing role in the diagnosis, characterization, and therapy guidance in pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Markers involved in resistance to cytotoxics and targeted therapeutics in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Biomarkers in the diagnosis and early detection of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Preoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for the evaluation of curability and resectability in patients with pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Early detection and biomarkers in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Validation of reverse phase protein array for practical screening of potential biomarkers in serum and plasma: accurate detection of CA19-9 levels in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Predictors of cancer in patients with suspected pancreatic malignancy without a tissue diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

TPS, CA 19-9, VEGF-A, and CEA as diagnostic and prognostic factors in patients with mass lesions in the pancreatic head

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Mucin expression profile in pancreatic cancer and the precursor lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Expression of Ki-67, p53, and K-ras in chronic pancreatitis and pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Analysis of Ki-67 antigen expression, DNA proliferative fraction, and survival in resected cancer of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Molecular prognostic markers in pancreatic cancer: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

p21 is a universal inhibitor of cyclin kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Correlation between TGF-beta1 and p21 (WAF1/CIP1) expression and prognosis in resectable invasive ductal carcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

DPC4/Smad4 Expression and Outcome in Pancreatic Ductal Adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Loss of p27 expression is associated with poor prognosis in stage I-II pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

p27Kip1 expression is reduced in pancreatic carcinoma but has limited prognostic value

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

K-ras oncogene subtype mutations are associated with survival but not expression of p53, p16(INK4A), p21(WAF-1), cyclin D1, erbB-2 and erbB-3 in resected pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Molecular prognostic factors in patients with pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Molecular analysis to detect pancreatic ductal adenocarcinoma in high-risk groups

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Assessment of soluble angiogenic markers in pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Usefulness of plasma vascular endothelial growth factor in the diagnosis of pancreatic carcinoma: differential diagnosis, tumor progression, and patient survival

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Multiplexed proximity ligation assays to profile putative plasma biomarkers relevant to pancreatic and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Serum vascular endothelial growth factor levels in pancreatic cancer patients correlate with advanced and metastatic disease and poor prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Expressions of angiogenic factors in pancreatic ductal carcinoma: a correlative study with clinicopathologic parameters and patient survival

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Serum markers in patients with resectable pancreatic adenocarcinoma: macrophage inhibitory cytokine 1 versus CA19-9

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Measurement of serum levels of macrophage inhibitory cytokine 1 combined with prostate-specific antigen improves prostate cancer diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Current status of tumor M2 pyruvate kinase (tumor M2-PK) as a biomarker of gastrointestinal malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Tumor M2-pyruvate kinase, a new metabolic marker for pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Tumor M2 pyruvate kinase: a tumor marker and its clinical application in gastrointestinal malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Tumor M2-Pyruvate Kinase as Tumor Marker in Exocrine Pancreatic Cancer A Meta-Analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

CEACAM1, a novel serum biomarker for pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Protein profiling of microdissected pancreas carcinoma and identification of HSP27 as a potential serum marker

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Clinical utility of quantitative RT-PCR targeted to alpha1,4-N-acetylglucosaminyltransferase mRNA for detection of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

The expression pattern of PDX-1, SHH, Patched and Gli-1 is associated with pathological and clinical features in human pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Tissue MicroArray analyses of pancreatic duodenal homeobox-1 in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

PDX-1 acts as a potential molecular target for treatment of human pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Maspin is useful in the distinction of pancreatic adenocarcinoma from chronic pancreatitis: a tissue microarray based study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Clinicopathological significance and molecular regulation of maspin expression in ductal adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Prognostic significance of maspin in pancreatic ductal adenocarcinoma: tissue microarray analysis of 223 surgically resected cases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Caveolin-1 overexpression correlates with tumour progression markers in pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Co-expression of fatty acid synthase and caveolin-1 in pancreatic ductal adenocarcinoma: implications for tumor progression and clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Tissue transglutaminase regulates focal adhesion kinase/AKT activation by modulating PTEN expression in pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Differential Diagnosis of Pancreatic Tumors by Molecular Analysis of Clinical Specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Expression of K homology domain containing protein overexpressed in cancer in pancreatic FNA for diagnosing adenocarcinoma of pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

High expression of HIF1a is a predictor of clinical outcome in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA, VEGF, and bFGF.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

CXCR2 and RET single nucleotide polymorphisms in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

S100P is an early developmental marker of pancreatic carcinogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Sp1, a new biomarker that identifies a subset of aggressive pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Polymorphisms of p16, p27, p73, and MDM2 modulate response and survival of pancreatic cancer patients treated with preoperative chemoradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Hypoxia-inducible proto-oncogene Pim-1 is a prognostic marker in pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

New markers of pancreatic cancer identified through differential gene expression analyses: claudin 18 and annexin A8.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Proteomic profiling of pancreatic cancer for biomarker discovery

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Pancreatic cancer proteome: the proteins that underlie invasion, metastasis, and immunologic escape

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Comparative proteomic analysis for the detection of biomarkers in pancreatic ductal adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Antiangiogenic treatment with three thrombospondin-1 type 1 repeats versus gemcitabine in an orthotopic human pancreatic cancer model

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Transforming growth factor beta I expression in benign and malignant prostatic tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Antiangiogenic therapy in human gastrointestinal malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

VEGF-RII influences the prognosis of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Human heparanase-1 gene expression in pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Expression of thrombospondin-1 in pancreatic carcinoma: correlation with microvessel density

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Expression of thrombospondin-1 in human pancreatic adenocarcinomas: role in matrix metalloproteinase-9 production

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Angiogenesis and cathepsin expression are prognostic factors in pancreatic adenocarcinoma after curative resection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Pancreas duodenal homeobox-1 expression and significance in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Expression of K homology domain containing protein (KOC) in pancreatic cytology with corresponding histology

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Reduced membranous and ectopic cytoplasmic expression of beta -catenin correlate with cyclin D1 overexpression and poor prognosis in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Dysregulation of beta-catenin expression correlates with tumor differentiation in pancreatic duct adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Immunohistochemical analysis of changes in signaling pathway activation downstream of growth factor receptors in pancreatic duct cell carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Pancreatic tumor cells with mutant K-ras suppress ERK activity by MEK-dependent induction of MAP kinase phosphatase-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Epidermal growth factor receptor-related protein inhibits cell growth and invasion in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Inhibition of STAT3 Tyr705 phosphorylation by Smad4 suppresses transforming growth factor beta-mediated invasion and metastasis in pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Smad4-mediated TGF-beta signaling in tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Focus on pancreas cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Expression of Smad2 and Smad4 in cervical cancer: absent nuclear Smad4 expression correlates with poor survival

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Adenovirus-mediated transfer of p53 and p16(INK4a) results in pancreatic cancer regression in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

The fate of pancreatic tumor cell lines following p16 overexpression depends on the modulation of CDK2 activity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Ras-driven transformation of human nestin-positive pancreatic epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

K-Ras promotes growth transformation and invasion of immortalized human pancreatic cells by Raf and phosphatidylinositol 3-kinase signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

TGFbeta signaling in growth control, cancer, and heritable disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Transforming growth factor-beta in cancer and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Hedgehog signaling in pancreas development and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Beta-catenin is a promising key factor in the SDF-1/CXCR4 axis on metastasis of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Common activation of canonical Wnt signaling in pancreatic adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Sonic hedgehog paracrine signaling regulates metastasis and lymphangiogenesis in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Developmental biology informs cancer: the emerging role of the hedgehog signaling pathway in upper gastrointestinal cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Sonic hedgehog is an early developmental marker of intraductal papillary mucinous neoplasms: clinical implications of mRNA levels in pancreatic juice.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Recent advances on the molecular mechanisms involved in pancreatic cancer progression and therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Inhibition of nuclear factor kappab activity by genistein is mediated via Notch-1 signaling pathway in pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Bcl-XL protein levels determine apoptotic index in pancreatic carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Apoptosis and expression of Bcl-2 and Bax proteins in invasive ductal carcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Detailed tissue expression of bcl-2, bax, bak and bcl-x in the normal human pancreas and in chronic pancreatitis, ampullary and pancreatic ductal adenocarcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Bcl-2 expression in pancreas development and pancreatic cancer progression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

bax, but not bcl-2, influences the prognosis of human pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Expression of the IAP protein family is dysregulated in pancreatic cancer cells and is important for resistance to chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Survivin expression is a prognostic marker in pancreatic cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Expression of Survivin in pancreatic cancer and its correlation to expression of Bcl-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Expression of survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein, in pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Effects and expression of TRAIL and its apoptosis-promoting receptors in human pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

The role of death receptor ligands in shaping tumor microenvironment

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Dual targeting of Raf and VEGF receptor 2 reduces growth and metastasis of pancreatic cancer through direct effects on tumor cells, endothelial cells, and pericytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Surrogate biomarkers in evaluating response to anti-angiogenic agents: focus on sunitinib

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Transforming growth factor alpha expression drives constitutive epidermal growth factor receptor pathway activation and sensitivity to gefitinib (Iressa) in human pancreatic cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Bortezomib sensitizes pancreatic cancer cells to endoplasmic reticulum stress-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Bortezomib is ineffective in an orthotopic mouse model of pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Phase II trial of curcumin in patients with advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Potent inhibitors of the hedgehog signaling pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

A small-molecule antagonist of the hedgehog signaling pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Small molecules with EGFR-TK inhibitor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

A review of kinases implicated in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Tumor-associated CD75s- and iso-CD75s-gangliosides are potential targets for adjuvant therapy in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Pancreatic cancer serum detection using a lectin/glyco-antibody array method

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Preoperative evaluation of pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Prognostic impact of perioperative serum CA 19-9 levels in patients with resectable pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

CA 19-9 as a predictor for response and survival in advanced pancreatic cancer patients treated with chemoradiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Identification of a biomarker panel using a multiplex proximity ligation assay improves accuracy of pancreatic cancer diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

MUC1 is a useful molecular marker for malignant intraductal papillary mucinous neoplasms in pancreatic juice obtained from endoscopic retrograde pancreatography

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Differential diagnosis of pancreatic cancer and focal pancreatitis by using EUS-guided FNA

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Improved diagnosis of pancreatic adenocarcinoma using haptoglobin and serum amyloid A in a panel screen.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Proteomic classification of pancreatic adenocarcinoma tissue using protein chip technology

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Single-nucleotide polymorphisms of DNA damage response genes are associated with overall survival in patients with pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Expression profiling identifies microRNA signature in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

MicroRNA Expression Abnormalities in Pancreatic Endocrine and Acinar Tumors Are Associated With Distinctive Pathologic Features and Clinical Behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

MicroRNA in pancreatic cancer: pathological, diagnostic and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

MALDI imaging mass spectrometry for direct tissue analysis: a new frontier for molecular histology

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

MALDI/SELDI protein profiling of serum for the identification of cancer biomarkers.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Strategies for discovering novel cancer biomarkers through utilization of emerging technologies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Increased PDX-1 expression is associated with outcome in patients with pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021

Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2810%2951006-0

7 January 2021